COVID-19 - One year on

Register now to attend our free webinar on 28th February (14:00 GMT, Sunday) looking back at the progress made in the battle against Coronavirus. With leading experts from around the world, the free webinar will establish how our therapeutic knowledge of treating COVID 19 has developed in the past year. It will provide information about vaccination in pregnancy and wider issues relating to global vaccination policy, and shed more light on the lessons of the large population based studies on COVID in pregnancy.

https://www.isuog.org/event/covid-19-one-year-on.html

Az Egészségügyi Világszervezet 2021. március 3-ig összesen 114,5 millió fertőzést, illetve 2,54 millió, a SARS-CoV-2 vírushoz (Covid-19) köthető haláleset regisztrált világszerte. A Magyarországon ismert halálesetek száma mára meghaladta a 15 000-et. Ahhoz, hogy a vakcinákra esetleg rezisztens mutáns vírusokkal nem is számolva a magyar lakosság legalább 60 százalékát aktív immunizációval védetté tegyük a fertőzéssel vagy betegséggel szemben, minimum több hónapra van szükség. 

A gyógyult betegek plazmáját felhasználó plazma-, illetve az intravénás immunoglobulin (IVIg)-terápia, amelyet nem csak klinikai vizsgálatokban lehet használni, alapvetően a passzív immunizáció elvét követi. A módszereket jóval specifikusabban és hatásosabban lehetne alkalmazni, amennyiben sikerülne azonosítani a tünetmentes fertőzés lefolyásáért felelős tényezőket.

Magyarországon a gyógyult betegek plazmájával jelenleg két konzorcium is folytat klinikai vizsgálatot. A Semmelweis Egyetem vezetésével folytatott vizsgálat során eddig 350, Covid-19 betegségben szenvedő beteget kezeltek több mint 600 egység plazmával.

A plazma- és az IVIg-terápiát ki kellene terjeszteni az orvosi gyakorlatra is.

1. Az eddig beadott plazmaegységek száma és az ijesztő halálozási adatok közötti óriási eltérés miatt

2. A jelenleg ismert terápiás hatás szerint is hatékony plazma IVIg kezelés eredményessége miatt - ezt mutatják az eddigi áttekintések

3. A donorplazma vagy a IVIg eddig kihasználatlan komplement aktivációt (és következményes citokinvihart) gátló hatása miatt

Valamennyi COVID osztály számára hasznos lehet a webináron való részvétel, hogy az eddig rendelkezésre álló bizonyítékok alapján tudják alkalmazni a plazma- és az IVIg-terápiát és ezzel minél több emberéletet lehessen megmenteni.

Az angol nyelvű szekció programja, moderator: Prof. Dr. Nacsa János (OVSz)

14.00  Prof. Dr. Milan Basta, a Biovisions Inc. (Egyesült Államok) elnöke:
A nagydózisú intravénás immunoglobulin (IVIg) alkalmazása, mint a komplement aktiváció modulátora: érvek a Covid-19 elleni bevetés mellett

14.15  Prof. Dr. Krzysztof Tomasiewicz, Lublini Orvosi Egyetem, Lengyelország:

A COVID-19 betegségben használt konvaleszcens plazma és specifikus immunglobulin indokoltsága, és a velük szerzett klinikai tapasztalatok

14.30  Dr. Ulrich Gockel, Biotest AG, Németország:
Pentaglobin, Trimodulin – IgM dús IVIg komplement aktiváció gátló hatása

14.45  Dr. Martin Reinecke, Biotest AG, Németország:
Convaleszcens plazma kezelés Covid-19-ben

15.00  Megbeszélés angol nyelven

A magyar nyelvű szekció programja:

15.20 – Kerekasztal-beszélgetés a konvaleszcens plazmával gyógyító-kutató orvosokkal

Moderátor: Prof. Dr. Lacza Zsombor (Testnevelési Egyetem, tudományos rektorhelyettes)

Résztvevők: Dr. Nagy Sándor (Országos Vérellátó Szolgálat, szakmai főigazgató), Dr. Szlávik János (főorvos, Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet), Prof. Dr. Müller Veronika (Semmelweis Egyetem, a Pulmonológiai Klinika igazgatója), Prof. Dr. Tordai Attila (Semmelweis Egyetem, a Transzfúziológiai Tanszék vezetője), Prof. Dr. Nacsa János (Országos Vérellátó Szolgálat, kutatási és fejlesztési igazgató).

15.50  - Következtetések
A konvaleszcens plazma és IVIg kezelés irányelvei a jelenleg rendelkezésre álló bizonyítékok és klinikai vizsgálatok tapasztalatai alapján

Dear Friends and Colleagues,

The Congress of the European Association of Dermato-Oncology (EADO) is now a very well established scientific meeting, and has participants not only from Europe, but from all continents of the world. It is the largest congress in dermato-oncology and there are no competing congresses in this field.

The 18th EADO Congresswill be hosted in the amazing city of Seville, Spain and will be a hybrid event comprising both an in-person conference and a virtual conference. We believe it will be one of the first congresses where face-to-face meetings will once again be possible.

Each EADO congress brings with it a special area of emphasis and Seville has a clinical focus on both the early diagnosis of skin cancer and dermatosurgery as part of the integral approach to skin cancer patients. Consequently, the promising therapeutic landscape that the increasingly conservative surgery and the latest breakthroughs in immunotherapy and targeted therapy bring to skin cancer patients will be comprehensively discussed in Seville, with also special attention to dermoscopy and other diagnostic technologies.

Compared to previous congresses, there is a balanced offering of topics on melanoma and non-melanoma skin cancer.

The best experts worldwide have been invited as speakers and will offer you the opportunity to gain a comprehensive insight into all areas of dermato-oncology.

Some cities blast you away, others slowly win you over. Seville, the host city, disarms and seduces you. Its historic center, lorded over by a colossal Gothic cathedral, is an intoxicating mix of resplendent Mudéjar palaces, baroque churches and winding medieval lanes. Flamenco clubs keep the intimacy and intensity of this centuries-old tradition alive whilst aristocratic mansions recall the city’s past as a showcase Moorish capital. But while history reverberates all around, Seville is as much about the here and now as the past. It is about enjoying warm afternoons and evenings eating tapas in a buzzing plaza.

Join us at the 18th EADO Congress! We are convinced we will all enjoy this opportunity to gain the highest scientific knowledge in the field, surrounded by the most colorful Spring ever, Spring in Seville.

Warmest regards,

Prof. Dr. David Moreno-Ramírez                                   Prof. Dr. Claus Garbe
Seville, Spain                                                                 Tuebingen, Germany
Congress President                                                       Congress President

Geneva Health Forum, 3^rd to 5^th May 2022: "Covid-19 Pandemic and Environmental Emergency: Reinventing Global Health in Times of Global Changes"

The Geneva Health Forum (GHF) brings us together around major global health issues. It gives a voice to actors from the field and bridges them with policy-makers present in Geneva. It gives visibility to innovative, accessible and sustainable practices and tools and to important initiatives. After more than 15 years of existence, the GHF has become a crucial event in the field of global health.

For its ninth edition, which will take place from 3^rd to 5^th May 2022, the Geneva Health Forum will address crucial issues for our future. Under the theme “Covid-19 Pandemic and Environmental Emergency: Reinventing Global Health in Times of Global Changes”, the GHF will help us learn the lessons from the Covid-19 crisis and better understand the impact of environmental degradation on human health.

Indeed, the Covid-19 pandemic has highlighted our fragility as societies in the face of zoonoses, diseases that appear in the animal world and that can spread to human beings. Biodiversity loss and fragile ecosystems are factors that worsen this risk. Pollution and climate change are already having an impact on our health.

One thing is clear: our health is intrinsically linked to the health of the environment and global health must be revisited in the light of these implications. A paradigm shift is needed.

The Geneva Health Forum will provide a platform to help us better understand these issues and discover initiatives that can offer possible solutions.

Learn more about the thematic and discover the preliminary programme!

True to its spirit of networking platform, the GHF 2022 will be held face-to-face at the Geneva International Conference Center (CICG). In order to allow our public who cannot join us to participate in the event remotely, we will broadcast a selection of panels on a digital platform.

Finally, the GHF will offer the opportunity to visit the Global Health Lab, our innovation fair, where more than 100 innovations will be present. The booths of our partners and our contributors will welcome you to discuss on many themes and the scientific posters selected for you await you both on site and on our digital platform.

Register now to take advantage of Early Bird rates

valid until 31^st March!
REGISTRATION

Geneva Health Forum, 3^rd to 5^th May 2022: "Covid-19 Pandemic and Environmental Emergency: Reinventing Global Health in Times of Global Changes"

The Geneva Health Forum (GHF) brings us together around major global health issues. It gives a voice to actors from the field and bridges them with policy-makers present in Geneva. It gives visibility to innovative, accessible and sustainable practices and tools and to important initiatives. After more than 15 years of existence, the GHF has become a crucial event in the field of global health.

For its ninth edition, which will take place from 3^rd to 5^th May 2022, the Geneva Health Forum will address crucial issues for our future. Under the theme “Covid-19 Pandemic and Environmental Emergency: Reinventing Global Health in Times of Global Changes”, the GHF will help us learn the lessons from the Covid-19 crisis and better understand the impact of environmental degradation on human health.

Indeed, the Covid-19 pandemic has highlighted our fragility as societies in the face of zoonoses, diseases that appear in the animal world and that can spread to human beings. Biodiversity loss and fragile ecosystems are factors that worsen this risk. Pollution and climate change are already having an impact on our health.

One thing is clear: our health is intrinsically linked to the health of the environment and global health must be revisited in the light of these implications. A paradigm shift is needed.

The Geneva Health Forum will provide a platform to help us better understand these issues and discover initiatives that can offer possible solutions.

Learn more about the thematic and discover the preliminary programme!

True to its spirit of networking platform, the GHF 2022 will be held face-to-face at the Geneva International Conference Center (CICG). In order to allow our public who cannot join us to participate in the event remotely, we will broadcast a selection of panels on a digital platform.

Finally, the GHF will offer the opportunity to visit the Global Health Lab, our innovation fair, where more than 100 innovations will be present. The booths of our partners and our contributors will welcome you to discuss on many themes and the scientific posters selected for you await you both on site and on our digital platform.

Register now to take advantage of Early Bird rates

valid until 31^st March!
REGISTRATION